UVA researchers take on antibiotic resistance crisis with $1.2 million grant

University of Virginia researchers are working to outrace two dangerous germs known for quickly developing resistance to new antibiotics – and the scientists’ efforts could help us better combat antibiotic resistance more broadly.

Stem-Cell Mobilization Booster Wins FDA Approval for Multiple Myeloma

The FDA has approved the CXCR4 antagonist motixafortide (Aphexda) for use with filgrastim (Neupogen) to mobilize stem cells for autologous transplantation in multiple myeloma, BioLineRx

September 12, 2023

Automation Fills Gaps Left by Revenue Cycle Talent Shortage

Noel A. Felipe, CRCR, SVP & Revenue Cycle Practice Leader, Firstsource Healthcare providers are feeling the industry’s talent shortage in their administrative functions as well

October 9, 2023

Eli Lilly and Innovent’s obesity drug mazdutide achieves positive Phase III results

Share this article The Phase III trials have shown a similar safety profile to previous trials of mazdutide. Credit: Pixel-Shot via Shutterstock. Innovent has reported

January 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.